JMP Securities analyst Constantine Davides reiterated a Buy rating on Option Care Health (OPCH – Research Report) and kept the price target at $36. 00.
According to TipRanks, Davides is an analyst with an average return of -21. 6% and a good luck rate of 33. 33%. Davides covers the healthcare sector, focusing on stocks such as OptimizeRx, Evolent Health, and Certara.
In the report published today, Goldman Sachs also maintained a buy level of shares with a price target of $41. 00.
TipRanks tracks more than 100,000 corporate experts, identifying the select few who excel at synchronizing their operations. By upgrading to TipRanks Premium, gain access to this proprietary knowledge and discover critical insights to inform your investment decisions. Start your TipRanks Premium adventure today.
Option Care Health (OPCH) Company Description:
Option Care Health, Inc. provides infusion at home and elsewhere. The company was founded in 1996 and is headquartered in Bannockburn, Illinois.
Learn more about OPCH: